Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study. | Dermatol Ther (Heidelb) | 2025 | 39982649 | PubTator, text mining | PubMed |
| Triptolide combined with salvianolic acid B alleviates CCL4-induced liver fibrosis by suppressing the Th17/IL-17A axis. | Int Immunopharmacol | 2025 | 39965387 | PubTator, text mining | PubMed |
| Interleukin 17 RA and RC gene polymorphisms and increased preeclampsia risk: Single and combined genetic analysis. | Hum Immunol | 2025 | 39908641 | PubTator, text mining | PubMed |
| IL-17A, IL-23R, FCGR3A are associated with neuropsychiatric systemic lupus erythematosus susceptibility in pediatric patients with lupus nephritis. | Cytokine | 2025 | 39904110 | PubTator, text mining | PubMed |
| Dahuang chuanxiong decoction against contrast-induced nephropathy: Multi-omics, crosstalk between BNIP3-mediated mitophagy and IL-17 pathway. | Phytomedicine | 2025 | 39889489 | PubTator, text mining | PubMed |
| Genetic Variants of the IL-23/IL-17 Axis and Its Association With Periodontal Disease: A Systematic Review. | Immun Inflamm Dis | 2025 | 39887950 | PubTator, text mining | PubMed |
| Why Anti-IL-17 Therapy Fails: The Role of Autonomous IL-17R Signaling in Autoimmune Inflammation. | Allergy | 2025 | 39878040 | PubTator, text mining | PubMed |
| Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders. | Cytokine Growth Factor Rev | 2025 | 39875232 | PubTator, text mining | PubMed |
| IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo. | Cell Immunol | 2025 | 39837005 | PubTator, text mining | PubMed |
| A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system. | Sci Rep | 2025 | 39824966 | PubTator, text mining | PubMed |
| RORγt inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis. | PLoS One | 2025 | 39820614 | PubTator, text mining | PubMed |
| IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination. | BMC Cancer | 2025 | 39810133 | PubTator, text mining | PubMed |
| Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping. | Sci Rep | 2025 | 39809837 | PubTator, text mining | PubMed |
| Balanced diets are associated with a lower risk of type 2 diabetes than plant-based diets. | Diabetes Res Clin Pract | 2025 | 39736334 | PubTator, text mining | PubMed |
| Aberrant Chitinase 3-Like 1 Expression in Basal Cells Contributes to Systemic Sclerosis Fibrosis. | Adv Sci (Weinh) | 2025 | 39686726 | PubTator, text mining | PubMed |
| IL-17A-Induced Redox Imbalance and Inflammatory Responses in Mice Lung via Act1-TRAF6-IKBα Signaling Pathway: Implications for Lung Disease Pathogenesis. | Inflammation | 2025 | 39607627 | PubTator, text mining | PubMed |
| Brodalumab: Six-Year US Pharmacovigilance Report. | Dermatol Ther (Heidelb) | 2025 | 39589679 | PubTator, text mining | PubMed |
| IL-17A is a key regulator of neuroinflammation and neurodevelopment in cognitive impairment induced by sevoflurane. | Free Radic Biol Med | 2025 | 39581388 | PubTator, text mining | PubMed |
| Structure-based design and disulfide stapling of interfacial cyclic peptidic inhibitors from thymic stromal lymphopoietin (TSLP) receptor to competitively target TSLP. | Biochimie | 2025 | 39571720 | PubTator, text mining | PubMed |
| Integrated proteomics and scRNA-seq analyses of ovarian cancer reveal molecular subtype-associated cell landscapes and immunotherapy targets. | Br J Cancer | 2025 | 39548315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=10